GlaxoSmithKline
Jul 7, 2008
Adolor Provides Update On Entereg (alvimopan) Obd Program - Fda Lifts Clinical Hold On Obd Ind
Main Category: GastroIntestinal / Gastroenterology Also Included In: Clinical Trials / Drug Trials Adolor Corporation today issued an update on the Entereg Program for chronic opioid bowel dysfunction , under ...
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| 'Hundreds' more claim thyroid drug side-effects | 3 hr | J Wynyard- W... | 9 |
| Psychiatrist Accused of $2.8 Million Payola Fro... | Oct 7 | HumanSpirit | 3 |
| FDA Warns of Suicide Risk for Paxil (from May '06) | Oct 5 | Lis | 70 |
| Fluticasone now in generic, sort of (from Jun '06) | Oct 3 | Leigh | 56 |
| Pazopanib Shows Encouraging Activity In Several... | Sep 29 | catherine | 1 |
| GlaxoSmithKline buys Lovaza-maker Reliant for $... | Sep 21 | Yvonna | 1 |
| Family may sue Paxil over teen suicide | Sep 16 | frusciante | 1 |
Gemini
Most Popular